Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Up 39.9% in November

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the target of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 51,200 shares, an increase of 39.9% from the November 15th total of 36,600 shares. Based on an average trading volume of 13,600 shares, the short-interest ratio is presently 3.8 days.

Conduit Pharmaceuticals Price Performance

CDTTW remained flat at $0.02 during trading on Friday. The company’s stock had a trading volume of 49,612 shares, compared to its average volume of 18,373. The stock has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.02. Conduit Pharmaceuticals has a 12-month low of $0.01 and a 12-month high of $0.15.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.